tiprankstipranks
Trending News
More News >
China Sxt Pharmaceuticals (SXTC)
:SXTC
Advertisement

China SXT Pharmaceuticals (SXTC) Price & Analysis

Compare
273 Followers

SXTC Stock Chart & Stats


Financials

Options Prices

Currently, No data available
---

Ownership Overview

0.44%100.00%
Insiders
Mutual Funds
0.44% Other Institutional Investors
100.00% Public Companies and
Individual Investors

SXTC FAQ

What was China Sxt Pharmaceuticals’s price range in the past 12 months?
China Sxt Pharmaceuticals lowest stock price was $0.95 and its highest was $10.24 in the past 12 months.
    What is China Sxt Pharmaceuticals’s market cap?
    China Sxt Pharmaceuticals’s market cap is $187.96M.
      When is China Sxt Pharmaceuticals’s upcoming earnings report date?
      The company’s upcoming earnings report date is not yet available.
      How were China Sxt Pharmaceuticals’s earnings last quarter?
      Currently, no data Available
      Is China Sxt Pharmaceuticals overvalued?
      According to Wall Street analysts China Sxt Pharmaceuticals’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does China Sxt Pharmaceuticals pay dividends?
        China Sxt Pharmaceuticals does not currently pay dividends.
        What is China Sxt Pharmaceuticals’s EPS estimate?
        China Sxt Pharmaceuticals’s EPS estimate for its next earnings report is not yet available.
        How many shares outstanding does China Sxt Pharmaceuticals have?
        China Sxt Pharmaceuticals has 116,027,756 shares outstanding.
          What happened to China Sxt Pharmaceuticals’s price movement after its last earnings report?
          Currently, no data Available
          Which hedge fund is a major shareholder of China Sxt Pharmaceuticals?
          Currently, no hedge funds are holding shares in SXTC

          China SXT Pharmaceuticals Stock Smart Score

          Company Description

          China Sxt Pharmaceuticals

          China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine piece tablets (TCMP) in China. The company offers advanced, fine, and regular TCMP products, such as ChenXiang, SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, and ShaRen. It provides its products under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands. As of March 31, 2022, it had an end-customer base of 68 pharmaceutical companies, 14 chain pharmacies, and 20 hospitals in 10 provinces and municipalities in China. The company was founded in 2005 and is headquartered in Taizhou, China.
          Similar Stocks
          Company
          Price & Change
          Follow
          Durect
          Rockwell Med
          Organogenesis Holdings
          Kala Pharmaceuticals
          Flora Growth
          Popular Stocks
          What am I Missing?
          Make informed decisions based on Top Analysts' activity
          Know what industry insiders are buying
          Get actionable alerts from top Wall Street Analysts
          Find out before anyone else which stock is going to shoot up
          Get powerful stock screeners & detailed portfolio analysis